Burnett Patrick's Form 4 filing
Arcutis Biotherapeutics, Inc. (ARQT) · filed Aug 13, 2026
- Accession no.
- 0001628280-26-056898
- Filed
- Aug 13, 2026, 8:06 PM ET
- Trade date
- Aug 11-12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $394.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burnett PatrickCIK 0001741987 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Common Stock | MOption exerciseAcquired | +8,300 | $3.64 | +$30,212 | 127,589 | Direct | |
| Aug 11, 2026 | Common Stock | SSaleDisposed | −8,300 | $26.52 | −$220,129.28 | 119,289 | Direct | |
| Aug 12, 2026 | Common Stock | MOption exerciseAcquired | +6,700 | $3.64 | +$24,388 | 125,989 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −6,700 | $26.08 | −$174,767.49 | 119,289 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Common Stock | MOption exerciseDisposed | −8,300 | $0.00 | $0 | 135,450 | Direct | |
| Aug 12, 2026 | Common Stock | MOption exerciseDisposed | −6,700 | $0.00 | $0 | 128,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.